Third Rock Ventures GP V, LP - Insider Non-Derivative Transactions at Maze Therapeutics, Inc. (MAZE) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Nov 4, 2025, Third Rock Ventures GP V, LP's relationship to Maze Therapeutics, Inc. (MAZE) is TenPercentOwner, and currently has 4,473,958 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other MAZE insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Third Rock Ventures GP V, LP - Insider Non-Derivative Transactions of MAZE Common Stock

Third Rock Ventures GP V, LP - Insider Non-Derivative Transactions at MAZE

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 5, 2025	J -- (Common Stock)	1600000	0	4473958